Exelixis: Pay

Exelixis paid its 5 named executives $73.0M in total in FY2025 (Jan). CEO Michael M. Morrissey was paid $33.2M of that.

Pay$100 in the stock at the end of FY21 → $149
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Michael M. MorrisseyPresident and Chief Executive Officer
FY2025 (Jan)
FY2024 (Jan)
FY2023 (Jan)
FY2022 (Jan)Not disclosed
4 years
Amy C. Peterson, M.D.Former Executive Vice President, Medical Affairs, and Chief Medical Officer
FY2025 (Jan)
FY2024 (Jan)
2 years
Christopher J. SennerExecutive Vice President and Chief Financial Officer
FY2025 (Jan)
FY2024 (Jan)
FY2023 (Jan)
FY2022 (Jan)Not disclosed
4 years
Patrick J. HaleyExecutive Vice President, Commercial
FY2025 (Jan)
1 year
Jeffrey J. Hessekiel, J.D.Former Executive Vice President, General Counsel
FY2025 (Jan)
FY2024 (Jan)
FY2023 (Jan)
FY2022 (Jan)Not disclosed
4 years
Dana T. Aftab, Ph.D.Executive Vice President, Research and Development
FY2024 (Jan)
1 year

CEO pay against the pay peers

In FY2025 (Jan), the median CEO pay of the 9 peers with pay on file was $15.0M. The CEO of Exelixis was paid $33.2M, 122% above the median.

  1. 1Exelixis
  2. 2Incyte
  3. 3Halozyme Therapeutics
  4. 4Biomarin Pharmaceutical
  5. 5United Therapeutics
  6. 6Natera
  7. 7Alnylam Pharmaceuticals
  8. 8Ionis Pharmaceuticals
  9. 9Alkermes plc.
  10. 10Neurocrine Biosciences
  11. 11ACADIA Pharmaceuticals Inc.Not disclosed
  12. 12BeiGene, Ltd.Not disclosed
  13. 13Exact Sciences CorporationNot disclosed
  14. 14Jazz PharmaceuticalsNot disclosed
  15. 15NovoCure LimitedNot disclosed
  16. 16PTC Therapeutics, Inc.Not disclosed
  17. 17Sarepta Therapeutics, Inc.Not disclosed
  18. 18Ultragenyx Pharmaceutical Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.